Birute Tumiene

Prof. Dr. Birute Tumiene

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Journal of Community Genetics
Verified
Journal Article
Closed access
PDF file
BTBirute Tumiene
Birute Tumiene
HGHolm Graessner
Holm Graessner

17 March 2021 in Journal of Community Genetics
Verified
Journal Article
Closed access
PDF file
BTBirute Tumiene
Birute Tumiene
HGHolm Graessner
Holm Graessner
IMIrene Mj Mathijssen
Irene Mj Mathijssen
APAlberto M Pereira
Alberto M Pereira
FSFranz Schaefer
Franz Schaefer
NHNicoline Hoogerbrugge
Nicoline Hoogerbrugge

29 December 2017 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
BTBirute Tumiene
Birute Tumiene
AMA. Maver
A. Maver
KWK. Writzl
K. Writzl
AHA. Hodžić
A. Hodžić
GČG. Čuturilo
G. Čuturilo
BPBorut Peterlin
Borut Peterlin

12 March 2022 in Genes
Verified
Journal Article
Open access
PDF file
BTBirute Tumiene
Birute Tumiene
BTBirute Tumiene
Birute Tumiene
CKClara D. M. van Karnebeek
Clara D. M. van Karnebeek
Understanding the genetic architecture of metabolic epilepsies is of paramount importance, both to current clinical practice and for the identification of further research directions. The main goals of our study were to identify the scope of metabolic epilepsies and to investigate their clinical presentation, diagnostic approaches and treatments. The International Classification of Inherited Metabolic Disorders and IEMbase were used as a basis for the identification and classification of metabolic epilepsies. Six hundred metabolic epilepsies have been identified, accounting for as much as 37% of all currently described inherited metabolic diseases (IMD). Epilepsy is a particularly common symptom in disorders of energy metabolism, congenital disorders of glycosylation, neurotransmitter disorders, disorders of the synaptic vesicle cycle and some other IMDs. Seizures in metabolic epilepsies may present variably, and most of these disorders are complex and multisystem. Abnormalities in routine laboratory tests and/or metabolic testing may be identified in 70% of all metabolic epilepsies, but in many cases they are non-specific. In total, 111 metabolic epilepsies (18% of all) have specific treatments that may significantly change health outcomes if diagnosed in time. Although metabolic epilepsies comprise an important and significant group of disorders, their real scope and frequency may have been underestimated.

21 September 2017 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
BTBirute Tumiene
Birute Tumiene
ŽČŽ. Čiuladaitė
Ž. Čiuladaitė
EPE. Preikšaitienė
E. Preikšaitienė
RMR. Mameniškienė
R. Mameniškienė
AUA. Utkus
A. Utkus
VKV. Kučinskas
V. Kučinskas

11 December 2023 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
BTBirute Tumiene
Birute Tumiene
AJAugutė Juozapavičiūtė
Augutė Juozapavičiūtė
VAVytenis Andriukaitis
Vytenis Andriukaitis
Despite general advancements in population health indicators and universal health coverage, people living with rare diseases and their families still experience considerable unmet needs, including prolonged diagnostic journeys, limited treatment options, and a huge psychosocial burden due to the lack of coordinated, integrated care. Attainment of universal health coverage for rare diseases is dependent on fundamentally different health determinants and demands for different solutions. This involves consolidating expertise through Centers of Excellence, establishing efficient care pathways, fostering extensive collaboration at European and global levels in research and healthcare, and putting patients at the center of care. Furthermore, development of specific indicators and coding systems is crucial for monitoring progress. Only in this way Europe can strive towards a future where people living with rare diseases receive the same level of equitable, safe, high-quality healthcare as other members of the society, in alignment with the overarching goal of leaving no one behind.